Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06182878 · ClinicalTrials.gov registry record · NA
Tender Loving Care for Recurrent Pregnancy Loss
A NA study of Recurrent Pregnancy Loss, sponsored by Walter Reed National Military Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06182878: Recruiting NA study of Recurrent Pregnancy Loss, sponsored by Walter Reed National Military Medical Center.
NCT06182878 is a NA study of Recurrent Pregnancy Loss that is actively recruiting participants, run by Walter Reed National Military Medical Center. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06182878, a NA study of Recurrent Pregnancy Loss, is actively recruiting participants, sponsored by Walter Reed National Military Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this investigational study is to evaluate participation in a weekly, interactive, tender loving care messaging platform impact on pregnancy outcomes in patients with recurrent pregnancy loss. The main questions it aims to answer are: (1) does participation in weekly, interactive tender loving care messages increase live birth rates in patients with recurrent pregnancy loss? (2) Does participation in weekly, interactive tender loving care messages increase patients' quality of life? Does participation in weekly, interactive tender loving care messages decrease patients' depressive symptoms? Participants will be asked to interact with weekly messages providing prenatal counseling and support. Additionally, patients will be asked to complete the fertility quality of life survey several times over the course of the pregnancy.
Primary Outcome
Live birth is defined as the delivery of at least one live-born infant at or after 22+0 weeks gestational age
Conditions Studied
Interventions
- BEHAVIORAL Tender loving care intervention
Study Locations (1)
Maryland
- Walter Reed National Military Medical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2025-12-01 |
| Phase | NA |
What NCT06182878 shows while recruiting
NCT06182878 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Recurrent Pregnancy Loss appearing as the primary indexed condition, and to 1 intervention - of which Tender loving care intervention is the first listed.
NCT06182878 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06182878 about?
NCT06182878 is a clinical study titled "Tender Loving Care for Recurrent Pregnancy Loss". The goal of this investigational study is to evaluate participation in a weekly, interactive, tender loving care messaging platform impact on pregnancy outcomes in patients with recurrent pregnancy loss. The main questions it aims to answer are: (1) does participation in weekly, interactive tender ...
What is the current status of trial NCT06182878?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-01-01. Estimated completion is 2025-12-01.
What conditions does trial NCT06182878 study?
This clinical trial studies the following conditions: Recurrent Pregnancy Loss.
What interventions are being tested in trial NCT06182878?
The interventions under investigation include: Tender loving care intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06182878?
This trial is sponsored by Walter Reed National Military Medical Center, which has 48 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06182878 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Recurrent Pregnancy Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06182878's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI